Design Therapeutics, Inc. — Investor Relations & Filings
Design Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a new class of small molecule therapies for genetic diseases. The company's proprietary GeneTAC® (Gene Targeted Chimera) platform is used to design therapeutic candidates that target the underlying cause of genetic disorders. These molecules are engineered to modulate gene expression—either increasing or decreasing it as needed—without requiring gene editing. The company's initial focus is on monogenic diseases driven by nucleotide repeat expansions, with programs targeting conditions such as Friedreich ataxia, myotonic dystrophy, Fuchs endothelial corneal dystrophy, and Huntington’s disease. The company aims to develop functional cures for patients with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| DEF 14A - Design Therapeutics, Inc. (0001807120) (Filer) | 2026-04-23 | English | |
| ARS - Design Therapeutics, Inc. (0001807120) (Filer) | 2026-04-23 | English | |
| 8-K - Design Therapeutics, Inc. (0001807120) (Filer) | 2026-04-01 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 8-K Filing | 2026-01-30 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 46384073 | 8-K | 2026-05-18 | English | ||
| 35871696 | DEF 14A - Design Therapeutics, Inc. (0001807120) (Filer) | 2026-04-23 | English | ||
| 35866025 | ARS - Design Therapeutics, Inc. (0001807120) (Filer) | 2026-04-23 | English | ||
| 33149832 | 8-K - Design Therapeutics, Inc. (0001807120) (Filer) | 2026-04-01 | English | ||
| 31799674 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31799643 | 8-K Filing | 2026-01-30 | English | ||
| 13247109 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13247107 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13247108 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13247110 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13247111 | Director's Dealing 2026 | 2026-01-05 | English | ||
|
2025
4 filings
| |||||
| 13247112 | Director's Dealing 2025 | 2025-12-11 | English | ||
| 13247113 | Major Shareholding Notification 2025 | 2025-11-18 | English | ||
| 13247114 | Regulatory Filings 2025 | 2025-11-18 | English | ||
| 13247115 | Regulatory Filings 2025 | 2025-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IBEX TECHNOLOGIES INC.
Develops and manufactures high-purity enzymes and specializ…
|
IBT | CA | Manufacturing |
|
iBio, Inc.
Preclinical biotech using an AI platform to develop antibod…
|
IBIO | US | Manufacturing |
|
Icure Pharmaceutical Incorporation
A biopharmaceutical firm specializing in Transdermal Drug D…
|
175250 | KR | Manufacturing |
|
ID Biomedical Corporation
Researched, developed, and manufactured innovative vaccines…
|
IDBE | CA | Manufacturing |
|
IDEAYA Biosciences, Inc.
Clinical-stage oncology company developing targeted therapi…
|
IDYA | US | Manufacturing |
|
Idorsia Ltd
Biopharmaceutical company developing small-molecule medicin…
|
IDIA | CH | Manufacturing |
|
IDT AUSTRALIA LIMITED
Specializes in high-potency API development and manufacturi…
|
IDT | AU | Manufacturing |
|
ILDONG HOLDINGS CO.,LTD
A holding company managing a diversified healthcare group i…
|
000230 | KR | Manufacturing |
|
IL DONG PHARMACEUTICAL CO., LTD.
Develops, manufactures, and commercializes a broad range of…
|
249420 | KR | Manufacturing |
|
ILSUNG IS CO., LTD.
Develops and manufactures antibiotics, cardiovascular agent…
|
003120 | KR | Manufacturing |
Design Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33059/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33059 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33059 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33059 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33059}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Design Therapeutics, Inc. (id: 33059)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.